Keyphrases
Colorectal Cancer
100%
COVID-19
48%
Healthcare Workers
41%
Cancer Organoids
31%
Consensus Molecular Subtypes
28%
Patient-derived Organoids
28%
Encorafenib
25%
Mitogen-activated Protein Kinase
25%
Tea Consumption
25%
Disease Susceptibility
25%
Graves' Disease
25%
Chinese Population
25%
Diagnostic Test
25%
Non-synonymous SNP
25%
BRAF mutant
25%
Protective Barrier
25%
Immune Checkpoint Blockade
25%
Immune Response
25%
Biobank
25%
KRAS mutation
25%
Paradox Breaker
25%
SARS-CoV-2 Seroprevalence
25%
Susceptibility Loci
25%
Renal Function
25%
Viral
25%
Severe Acute Respiratory Syndrome
25%
BRAF Inhibitor (BRAFi)
25%
Rapid Implementation
25%
WTCCC
25%
Cold-chain-free
25%
SARS-CoV-2 Diagnostics
25%
Surge Capacity
25%
Immune Infiltration
25%
PI3K Signaling
25%
Targets for Therapy
25%
Radioresistance
25%
Expression Pattern
25%
MHC Class II
25%
Tumor-specific
25%
Distinct Patterns
25%
SARS-CoV-2 RNA
21%
Seroprevalence
20%
Cancer Cells
19%
CIITA
17%
KRAS mutant
16%
Clinical Laboratory
16%
Throat Swab
16%
PLX8394
16%
Organoids
14%
Shock Waves
12%
Immunology and Microbiology
Organoid
50%
Radioresistance
25%
Severe Acute Respiratory Syndrome
25%
Immune Checkpoint Blockade
25%
MHC Class II
25%
COVID-19
25%
Immune Response
25%
Immune Cell Infiltration
25%
STAT1
21%
CXCL10
18%
Upregulation
17%
Cancer Cell
15%
Interferon Gamma
12%
Immunotherapy
12%
CIITA
12%
Cell Line
12%
Immune System
12%
Neutrophil
12%
Virus
12%
Immunity
11%
Radiosensitization
10%
Single-Cell Sequencing
10%
RNA Sequence
7%
Promoter Region
7%
Methylation
7%
Cytotoxic T-Cell
6%
Neoantigen
6%
Wild Type
6%
Cytotoxic T Cell
6%
RNA Sequencing
6%
Protein Expression
6%
CRISPR/Cas9
5%
Genome Sequencing
5%
Colorectal Cancer Cell Line
5%
Transcriptome
5%
Epithelial Mesenchymal Transition
5%
Medicine and Dentistry
Organoid
50%
Colorectal Carcinoma
30%
Seroprevalence
25%
Cohort Analysis
25%
Cross Sectional Study
25%
Kidney Function
25%
Radiosensitivity
25%
Severe Acute Respiratory Syndrome Coronavirus 2
25%
Rectum Cancer
25%
Upregulation
17%
Specific Tumor
17%
Cancer Cell
15%
Radiation Therapy
15%
Glomerular Filtration Rate
12%
Cell Line
12%
Chemoradiotherapy
10%
Cas9
10%
Radiosensitization
10%
Mammalian Target of Rapamycin Inhibitor
10%
RNA Sequence
7%
Promoter Region
7%
Methylation
7%
Diseases
6%
PI3K/AKT/mTOR Pathway
5%
Mesenchymal-Epithelial Transition
5%
Clinical Trial
5%
Mammalian Target of Rapamycin
5%
Genome Sequencing
5%
Colorectal Cancer Cell Line
5%
Transcriptome
5%
Clustered Regularly Interspaced Short Palindromic Repeat
5%
Neoplasm
5%
Epigenetic Therapy
5%
